These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 18279705)
1. The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease. Falcone C; Geroldi D; Buzzi MP; Emanuele E; Yilmaz Y; Fontana JM; Vignali L; Boiocchi C; Sbarsi I; Cuccia M Arch Med Res; 2008 Apr; 39(3):320-5. PubMed ID: 18279705 [TBL] [Abstract][Full Text] [Related]
2. Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease. Falcone C; Campo I; Emanuele E; Buzzi MP; Zorzetto M; Sbarsi I; Cuccia M Int J Mol Med; 2004 Dec; 14(6):1061-4. PubMed ID: 15547674 [TBL] [Abstract][Full Text] [Related]
3. The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes. Kirbis J; Milutinović A; Steblovnik K; Teran N; Terzić R; Zorc M Coll Antropol; 2004 Dec; 28(2):611-6. PubMed ID: 15666591 [TBL] [Abstract][Full Text] [Related]
4. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Falcone C; Emanuele E; D'Angelo A; Buzzi MP; Belvito C; Cuccia M; Geroldi D Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1032-7. PubMed ID: 15731496 [TBL] [Abstract][Full Text] [Related]
5. -374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis. Falcone C; Campo I; Emanuele E; Buzzi MP; Geroldi D; Belvito C; Zorzetto M; Sbarsi I; Cuccia M Clin Chim Acta; 2005 Apr; 354(1-2):111-6. PubMed ID: 15748606 [TBL] [Abstract][Full Text] [Related]
6. Associations of -374T/A polymorphism of receptor for advanced glycation end products (RAGE) gene in Turkish diabetic and non-diabetic patients with coronary artery disease. Kucukhuseyin O; Aydogan HY; Isbir CS; Isbir T In Vivo; 2009; 23(6):949-54. PubMed ID: 20023238 [TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. Norhammar A; Malmberg K; Diderholm E; Lagerqvist B; Lindahl B; Rydén L; Wallentin L J Am Coll Cardiol; 2004 Feb; 43(4):585-91. PubMed ID: 14975468 [TBL] [Abstract][Full Text] [Related]
8. RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus. Peng WH; Lu L; Wang LJ; Yan XX; Chen QJ; Zhang Q; Zhang RY; Shen WF Arch Med Res; 2009 Jul; 40(5):393-8. PubMed ID: 19766904 [TBL] [Abstract][Full Text] [Related]
9. Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients. Kalousová M; Jáchymová M; Germanová A; Kubena AA; Tesar V; Zima T Kidney Blood Press Res; 2010; 33(1):30-6. PubMed ID: 20185929 [TBL] [Abstract][Full Text] [Related]
10. Family history, diabetes and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: A one-year follow-up study. Rizzo M; Barbagallo CM; Noto D; Pace A; Cefalú AB; Pernice V; Pinto V; Rubino A; Pieri D; Traina M; Frasheri A; Notarbartolo A; Averna MR Nutr Metab Cardiovasc Dis; 2005 Oct; 15(5):361-7. PubMed ID: 16216722 [TBL] [Abstract][Full Text] [Related]
11. The E-selectin S128R polymorphism is not a risk factor for coronary artery disease in patients with diabetes mellitus type 2. Endler G; Exner M; Raith M; Marculescu R; Mannhalter C; Endler L; Wojta J; Huber K; Wagner OF Thromb Res; 2003; 112(1-2):47-50. PubMed ID: 15013273 [TBL] [Abstract][Full Text] [Related]
12. The 3'-UTR C>T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease. Sentinelli F; Filippi E; Fallarino M; Romeo S; Fanelli M; Buzzetti R; Berni A; Baroni MG Nutr Metab Cardiovasc Dis; 2006 Jul; 16(5):345-52. PubMed ID: 16829343 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease. Rothenbacher D; Brenner H; Mertens T; Hoffmann MM; Hoffmeister A; Koenig W BMC Cardiovasc Disord; 2005 May; 5(1):10. PubMed ID: 15943888 [TBL] [Abstract][Full Text] [Related]
14. C677T polymorphism of the methylenetetrahydrofolate reductase gene is a risk factor of adverse events after coronary revascularization. Botto N; Andreassi MG; Rizza A; Berti S; Bevilacqua S; Federici C; Palmieri C; Glauber M; Biagini A Int J Cardiol; 2004 Sep; 96(3):341-5. PubMed ID: 15301885 [TBL] [Abstract][Full Text] [Related]
15. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333 [TBL] [Abstract][Full Text] [Related]
16. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients. Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065 [TBL] [Abstract][Full Text] [Related]
17. AGER gene -374T>A (rs1800624) polymorphism is not associated with the severity of non-diabetic coronary artery disease in Han Chinese. Lu W; Feng B; Liu F; Zhang D; Qian Q; Zhuang S; Qi W; Zhou H Clin Chem Lab Med; 2011 Mar; 49(3):547-9. PubMed ID: 21254849 [No Abstract] [Full Text] [Related]
18. Polymorphism of p53 gene codon 72 in Kuwaiti with coronary artery disease and diabetes. Alkhalaf M; Al-Bustan S; Hamoda H; Abdella N Int J Cardiol; 2007 Jan; 115(1):1-6. PubMed ID: 16797751 [TBL] [Abstract][Full Text] [Related]
19. eNOS gene intron 4 a/b VNTR polymorphism is a risk factor for coronary artery disease in Southern Turkey. Matyar S; Attila G; Acartürk E; Akpinar O; Inal T Clin Chim Acta; 2005 Apr; 354(1-2):153-8. PubMed ID: 15748612 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme insertion/deletion polymorphism in French Canadian subjects with premature coronary artery disease. Wesolowska E; Marcil M; Lussier-Cacan S; Davignon J; Latour Y; Genest J Pathol Biol (Paris); 1998 May; 46(5):295-300. PubMed ID: 9769888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]